Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122579) titled 'Single-Center, Randomized, Double-Blind Trial of Anrikefon versus Tramadol for Postoperative Nausea and Vomiting following Laparoscopic Bariatric Surgery' on April 15.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Beijing Friendship Hospital ,Capital Medical University

Condition: Postoperative nausea and vomiting (PONV)

Intervention: Trial Group:Anruikefen injection, single dose of 1µg/kg, administered once every 8 hours for a total of 7 doses within 48 hours first dose given within 3 hours postoperatively, diluted to 50ml and infused over 30 minutes Control Group:Tramadol ...